REGN

Regeneron Pharmaceuticals, Inc. (REGN)

Last Price$696.9(5.0%)
Market Cap$75.6B
LTM Gross margin
84.4%
5Y avg
87.0%
Biotechnology industry median
65.9%
Stock quality & Intrinsic value
6/10
0.3% undervalued

Regeneron Pharmaceuticals, Inc. Gross margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
REGN
Healthcare
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Gross margin
91.3%
85.6%
87.2%
100.0%
99.6%
99.6%
99.5%
99.1%
93.9%
92.6%
92.7%
90.4%
93.8%
93.2%
93.5%
90.1%
86.8%
84.8%
87.2%
86.2%
REGN
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for REGN and see if it's the right time to invest.
Dive in

Regeneron Pharmaceuticals, Inc. (REGN) Gross margin comparison analysis

Crunching data... Almost there!

REGN key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Regeneron Pharmaceuticals, Inc.'s Gross margin?

As of today, Microsoft Corp's last 12-month Gross margin is 84.4%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Gross margin for Regeneron Pharmaceuticals, Inc. have been 86.3% over the past three years, and 91.4% over the past five years.

2) Is Regeneron Pharmaceuticals, Inc.'s Gross margin Good?

As of today, Regeneron Pharmaceuticals, Inc.'s Gross margin is 84.4%, which is higher than industry median of 65.9%. It indicates that Regeneron Pharmaceuticals, Inc.'s Gross margin is Good.

3) How does Regeneron Pharmaceuticals, Inc.'s Gross margin compare to its peers?

As of today, Regeneron Pharmaceuticals, Inc.'s Gross margin is 84.4%, which is lower than peer median of 85.7%. The list of peers includes GMAB, INCY, UTHR, ARGX, VRTX, ALNY, NVO, BNTX, BGNE, MRNA.